Clinical Leader Webinar

  1. Innovative Mobile Technologies For Clinical Trials And CRA Monitoring
    3/9/2016

    Learn about mobile innovation for virtual, hybrid, and site-based clinical trials using the Clinical Reach™ mClinical™ platform for patient enrollment, engagement, and management on a global scale. Followed by an in-depth Q&A session and Parallel 6 Chief Medical Officer, Brad Pruitt, M.D., MBA, who demonstrates the newly released mobile data monitoring solution which is designed to empower clinical research associates (CRAs). 

  2. The Importance Of Engaging A Patient’s Support System During A Clinical Trial
    3/9/2016

    Learn how innovative mobile technology helps clinical trial participants stay engaged and compliant through the empowerment of the patient’s loved ones. Speaker, Stephen J. Freedland, M.D. (Urologist at Cedars Sinai DEPT of Surgery), presents a compelling case discussion on the importance of patient compliance and market approval, followed by Chief Medical Officer of Parallel 6, Brad Pruitt, M.D., MBA, who demonstrates the new Clinical Reach™ companion app followed by an in-depth Q&A session covering clinical use and various trial applications.

  3. eCOA And Equivalence Testing: New Evidence From Meta-Analysis
    2/1/2016

    The evaluation of the compatibility between scores from an electronic version of a paper-based questionnaire, better known as equivalence testing, is usually taken as a requirement for ensuring that data from electronic versions of patient reported outcomes does not vary from that captured on paper. This webinar discusses the results of a recently published meta-analysis which examined all published equivalence tests from 2007 to 2013. This webinar discusses equivalence testing, how the current meta-analysis run, and what the results mean in context of the field of eCOA.

  4. Using ePRO With Smart Devices
    7/30/2015

    Interest in using electronic patient reported outcomes (ePRO) on smart devices is on the rise. In this webinar, Emily Cantrell and Becky Baggett will share lessons learned working on a large phase 3 pain study that utilizes ePRO on tablet devices.

  5. eSource Data Capture Simplified — Uncover Time and Cost Saving Possibilities
    6/3/2015

    This webinar will discuss some of the benefits of an eSource approach, which include eliminating double entry of data and the need for source data verification, reducing the need for data queries, and optimizing monitoring time. 

  6. Keys to Success for Your Integrated Summary of Safety (ISS) and Integrated Summary of Efficacy (ISE)
    4/23/2015

    Presenting the FDA with a coherent and clear integration of the data from your product development program is imperative and requires a sound strategy and a skillful approach.

  7. Strategies for Analgesic Development and the New FDA Guidance for Analgesic Indications
    4/23/2015

     In this webinar, Brett Gordon and Ben Vaughn provide a high-level review of the agency’s guidance, offer strategies for analgesic product development and share experiences with PROs and paper vs. tablet collection.

  8. Trial Master File (TMF) Reference Model
    4/23/2015

    In this webinar, Kristen Snipes, Project Director and Missy Lavinder, Senior Project Manager share tips and tricks for making the process manageable based on their own recent experience implementing the model.

  9. Leverage Your EDC Solution to Mitigate Risk in Clinical Research
    4/6/2015

    Every clinical trial is built upon a study protocol - the cornerstone of any trial. A well-defined and written study protocol provides the blueprint for the study, defining its purpose and goals.

  10. New FDA Guidance On Regulatory Submissions in Electronic Format
    3/17/2015

    In December 2014, FDA released the finalized Guidance for Industry “Providing Regulatory Submissions in Electronic Format—Standardized Study Data.” In this webinar, Rob Woolson and Ben Vaughn will review key points in the guidance followed by a discussion of the implications for Sponsors currently conducting studies as well as those who will be starting new studies soon.